Related Experiment Video
Updated: Jul 3, 2026

05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Trends in LVAD Placements and Outcomes: A Nationwide Analysis Using the National Inpatient Sample and National
Vivek Joseph Varughese1, Vignesh Krishnan Nagesh2, Hadrian Hoang-Vu Tran2
1Department of Internal Medicine, University of South Carolina, Prisma Health, 2 Med Park, Richland, WA 29203, USA.
Medical Sciences (Basel, Switzerland)
|May 23, 2025
Summary
Left Ventricular Assist Device (LVAD) placements decreased from 2016-2022, but those requiring Extracorporporeal Membrane Oxygenation (ECMO) support increased. ECMO use was significantly associated with higher in-hospital mortality for LVAD patients.
Area of Science:
- Cardiovascular Surgery
- Medical Device Technology
- Health Services Research
Background:
- Analysis of Left Ventricular Assist Device (LVAD) placement trends and outcomes from 2016-2022.
- Utilizing the National Inpatient Sample (NIS) database for comprehensive data.
- Focus on in-hospital outcomes and healthcare resource utilization.
Purpose of the Study:
- To analyze temporal trends in LVAD placements.
- To evaluate in-hospital outcomes and resource utilization associated with LVADs.
- To investigate the impact of Extracorporeal Membrane Oxygenation (ECMO) support on LVAD outcomes.
Main Methods:
- National Inpatient Sample (NIS) data from 2016-2022.
- Identification of LVAD placements using ICD-10 code 02HA0QZ.
- Stratification of outcomes by ECMO support (2018-2022) and multivariate regression analysis.
Main Results:
- A decreasing trend in overall LVAD placements (852 in 2016 to 665 in 2022).
- An increasing trend in LVAD admissions requiring ECMO support (2.21% in 2018 to 12.18% in 2022).
- Significant association between ECMO requirement and in-hospital all-cause mortality (OR 2.34, p=0.001).
Conclusions:
- Overall LVAD placement numbers declined, while ECMO utilization increased.
- In-hospital mortality and hospital charges remained stable.
- ECMO support during LVAD implantation is a significant predictor of in-hospital mortality.
- Heart failure is the primary cause for a 11.50% 30-day readmission rate.

